Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine for opioid-induced constipation in cancer pain (Phase III, China)
CTR20220673Phase 3Completed
- Sponsor
- Not applicable
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naldemedine in opioid-induced constipation (OIC), sponsored by Not applicable. Started Mar 2022; status: completed.
02
Drugs
naldemedine
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on CTR20220673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220673.